Deltroit Asset Management UK LLP purchased a new stake in Cameco Corporation (NYSE:CCJ – Free Report) (TSE:CCO) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 289,993 shares of the basic materials company’s stock, valued at approximately $26,531,000. Cameco comprises 3.9% of Deltroit Asset Management UK LLP’s holdings, making the stock its 6th largest holding. Deltroit Asset Management UK LLP owned 0.07% of Cameco at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Clearstead Advisors LLC increased its stake in shares of Cameco by 0.8% during the 4th quarter. Clearstead Advisors LLC now owns 10,158 shares of the basic materials company’s stock worth $929,000 after purchasing an additional 85 shares during the last quarter. Legacy Bridge LLC increased its stake in shares of Cameco by 0.9% during the 4th quarter. Legacy Bridge LLC now owns 11,508 shares of the basic materials company’s stock worth $1,053,000 after purchasing an additional 100 shares during the last quarter. S.A. Mason LLC increased its stake in shares of Cameco by 4.8% during the 4th quarter. S.A. Mason LLC now owns 2,436 shares of the basic materials company’s stock worth $223,000 after purchasing an additional 111 shares during the last quarter. GAMMA Investing LLC increased its stake in shares of Cameco by 19.9% during the 4th quarter. GAMMA Investing LLC now owns 676 shares of the basic materials company’s stock worth $62,000 after purchasing an additional 112 shares during the last quarter. Finally, Kingsview Wealth Management LLC increased its stake in shares of Cameco by 3.4% during the 4th quarter. Kingsview Wealth Management LLC now owns 3,435 shares of the basic materials company’s stock worth $314,000 after purchasing an additional 114 shares during the last quarter. 70.21% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on CCJ shares. Glj Research restated a “buy” rating and set a $171.20 price objective (up from $100.00) on shares of Cameco in a research note on Wednesday, February 18th. Scotiabank reaffirmed an “outperform” rating and set a $175.00 target price on shares of Cameco in a report on Wednesday, May 6th. Royal Bank Of Canada lifted their target price on shares of Cameco from $150.00 to $160.00 and gave the stock an “outperform” rating in a report on Tuesday, February 17th. Weiss Ratings downgraded shares of Cameco from a “hold (c+)” rating to a “hold (c)” rating in a report on Thursday. Finally, Zacks Research downgraded shares of Cameco from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 18th. Eleven research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $148.62.
Cameco Price Performance
CCJ stock opened at $103.52 on Friday. The company has a 50 day simple moving average of $113.70 and a 200 day simple moving average of $108.47. The stock has a market cap of $45.09 billion, a price-to-earnings ratio of 95.85, a P/E/G ratio of 1.93 and a beta of 0.99. Cameco Corporation has a 1 year low of $59.25 and a 1 year high of $135.24. The company has a debt-to-equity ratio of 0.14, a current ratio of 3.08 and a quick ratio of 2.09.
Cameco (NYSE:CCJ – Get Free Report) (TSE:CCO) last announced its quarterly earnings results on Tuesday, May 5th. The basic materials company reported $0.34 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.05. Cameco had a return on equity of 11.05% and a net margin of 18.38%.The firm had revenue of $607.49 million for the quarter, compared to analyst estimates of $598.63 million. During the same period last year, the firm posted $0.16 earnings per share. The business’s revenue for the quarter was up 7.1% on a year-over-year basis. Research analysts anticipate that Cameco Corporation will post 1.31 EPS for the current fiscal year.
About Cameco
Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.
The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.
Recommended Stories
- Five stocks we like better than Cameco
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Want to see what other hedge funds are holding CCJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cameco Corporation (NYSE:CCJ – Free Report) (TSE:CCO).
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.
